VRTX

Vertex Pharmaceuticals Inc

• Benzinga·1h ago

  Here's How Much $1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today

• Simply Wall St·9h ago

  What Vertex Pharmaceuticals (VRTX)'s Pediatric CF and Kidney Disease Data Means For Shareholders

• TipRanks·1d ago

  Vertex Pharmaceuticals (VRTX) Receives a Buy from Wells Fargo

• Benzinga·1d ago

  Vertex Says Pediatric CASGEVY Data Show Consistent Benefits In Rare Blood Disorders

• NASDAQ·1d ago

  Notable ETF Outflow Detected - JEPI, EOG, ETN, VRTX

• TipRanks·1d ago

  Analysts Are Bullish on Top Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Vertex Pharmaceuticals (VRTX)

• TipRanks·1d ago

  Vertex Pharmaceuticals presents new data on Casgevy at EHA

• Benzinga·1d ago

  Vertex Says CASGEVY Pediatric Data Demonstrate Transformative Potential In Children Ages 5–11 With Severe SCD And Transfusion-Dependent Beta Thalassemia

• PUBT·1d ago

  Vertex says FDA reviews CASGEVY label expansion to younger children with sickle cell, beta thalassemia

• Reuters·1d ago

  VERTEX PRESENTS NEW DATA ON CASGEVY®, INCLUDING FIRST EUROPEAN PRESENTATION OF DATA IN CHILDREN AGES 5–11, AT THE EUROPEAN HEMATOLOGY ASSOCIATION CONGRESS AND ANNOUNCES ADDITIONAL GLOBAL REGULATORY SUBMISSIONS

• PUBT·3d ago

  Vertex EVP and CMO Carmen Bozic sells 1,745 Vertex shares for $785,250

• Simply Wall St·3d ago

  Vertex Extends Cystic Fibrosis Reach With Pediatric ALYFTREK And TRIKAFTA Data

• Simply Wall St·06/05 16:29

  Assessing Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Gains And Renal Trial Progress

• TipRanks·06/05 16:05

  Vertex Pharmaceuticals presents data on ALYFTREK in children with CF

• TipRanks·06/05 13:20

  Vertex Pharmaceuticals (VRTX) Gets a Buy from Wells Fargo